Walleye Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Walleye Trading’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-14,862	Closed	-$969K	–	5710
2021 Q1	$1.03M	Buy	+14,862	New	+$1.14M	﹤0.01%	1888
2019 Q4	–	Sell	-333	Closed	-$15.7K	–	4757
2019 Q3	$15K	Sell	333 -7	-2%	-$393	﹤0.01%	3803
2019 Q2	$20K	Buy	+340	New	+$17.6K	﹤0.01%	3746
2019 Q1	–	Sell	-5,236	Closed	-$240K	–	4968
2018 Q4	$204K	Buy	+5,236	New	+$206K	﹤0.01%	3384
2017 Q2	–	Sell	-1,100	Closed	-$16K	–	5125
2017 Q1	$16K	Buy	+1,100	New	+$16.3K	﹤0.01%	4218
2015 Q3	–	Sell	-170	Closed	-$8K	–	5684
2015 Q2	$8K	Buy	+170	New	+$7.38K	﹤0.01%	4380

Walleye Trading's ARNA Position: Q2 2021 in Review

Walleye Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2021, closing a stake of 14,862 shares — an estimated $969K sold.

Walleye Trading first reported a position in ARNA in Q2 2015 and held it in 6 quarters. The position peaked at $1.03M in Q1 2021. 237 funds tracked by Wall St. Rank hold ARNA as of Q2 2021.

Walleye Trading reported no remaining Arena Pharmaceuticals Inc position as of Q2 2021 after selling out during the quarter.
Walleye Trading sold 14,862 Arena Pharmaceuticals Inc shares in Q2 2021, an estimated $969K.
Walleye Trading first reported a position in Arena Pharmaceuticals Inc in Q2 2015 and held it in 6 quarters.
Walleye Trading's Arena Pharmaceuticals Inc position peaked at $1.03M in Q1 2021.
237 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2021.

Based on Walleye Trading's 13F filing for Q2 2021, filed 16 Aug 2021.